Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Pred 814 dňami
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Pred 1080 dňami
Win Streak May Continue For South Korea Shares
The South Korea stock market has tracked higher in three straight sessions, advancing almost 200 points or 5 percent in that span. The KOSPI sits just above the 4,150-point plateau and it's tipped to open in the green again on Thursday.
RTTNews
|
Pred 1 h 17 min
Australia Unemployment Data Due On Thursday
Australia will on Thursday release October numbers for unemployment, highlighting a modest day for Asia-Pacific economic activity.
RTTNews
|
Pred 1 h 47 min
TSX Scales New Record High; Materials, Financials Stocks Among Top Gainers
Canada's S&P/TSX Composite Index surged to a new record high on Wednesday with stocks from materials, financials, consumer staples and industrials sectors turning in a strong performance.
The mood in the market is quite bullish amid hopes the government shutdown in the U.S. will come to end soon.
RTTNews
|
Pred 5 h 20 min
Swiss Market Settles On Firm Note
The Switzerland market closed on a firm note on Wednesday, tracking positive cues from other markets in Europe, amid rising prospects of an end to the U.S. government shutdown this week, and hopes about an interest rate cut by the Federal Reserve next month.
RTTNews
|
Pred 5 h 43 min
European Stocks Close On Firm Note
European stocks closed higher on Wednesday, extending recent gains, amid hopes the U.S. government shutdown will end soon, possibly even by this Friday.
Expectations of a rate cut by the Federal Reserve next month, and data showing a smaller than expected increase in Germany's consumer price inflation also contributed to markets' positive close.
RTTNews
|
Pred 5 h 56 min
Bay Street May Open On Positive Note Again
Canadian stocks may open higher on Wednesday amid optimism about an end to the U.S. government shutdown. Firm European stocks and expectations of an interest rate cut by the Federal Reserve next month may also help underpin sentiment.
RTTNews
|
Pred 10 h 19 min
